- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Health technology company Thorne HealthTech wrapped a downsized initial public offering Thursday, selling 7 million shares at $10 each, well below the $13 to $15 pricing range previously announced.
Shares of THRN debuted on the Nasdaq at $8.50.
What's in this guide?
- THRN shares summary
- Compare share dealing platforms
- Is THRN stock a buy or sell?
- Stock performance over time
- Can I short THRN shares?
- Are THRN shares over-valued?
- Thorne Healthtech's financials
- How volatile are THRN shares?
- Does Thorne Healthtech pay a dividend?
- Have THRN shares ever split?
- Other common questions
Our top picks for where to buy Thorne HealthTech stock
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Thorne Healthtech stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – THRN. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Thorne Healthtech stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Thorne Healthtech stock price (NASDAQ: THRN)
Use our graph to track the performance of THRN stocks over time.Thorne Healthtech shares at a glance
Information last updated 2024-06-30.
| Latest market close | $10.19 |
|---|---|
| 52-week range | $0.00 - $0.00 |
| 50-day moving average | $9.33 |
| 200-day moving average | $5.84 |
| Wall St. target price | $7.00 |
| PE ratio | 26.1282 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $0.39 |
Is it a good time to buy Thorne Healthtech stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Thorne Healthtech price performance over time
Historical closes compared with the close of $10.19 from 2023-10-16
| 1 week (2024-10-18) | N/A |
|---|---|
| 1 month (2024-09-25) | N/A |
| 3 months (2024-07-25) | N/A |
| 6 months (2024-04-25) | N/A |
| 1 year (2023-10-25) | N/A |
|---|---|
| 2 years (2022-10-28) | 100.20% |
| 3 years (2021-10-29) | 24.57% |
| 5 years (2019-10-25) | N/A |
Is Thorne Healthtech stock undervalued or overvalued?
Valuing Thorne Healthtech stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Thorne Healthtech's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Thorne Healthtech's P/E ratio
Thorne Healthtech's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 26x. In other words, Thorne Healthtech shares trade at around 26x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
However, Thorne Healthtech's P/E ratio is best considered in relation to those of others within the packaged foods industry or those of similar companies.
- Herbalife Nutrition (HLF.US): 8.43
- Cigna (CI.US): 25.12
- CVS Health (CVS.US): 9.99
Thorne Healthtech's EBITDA
Thorne Healthtech's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $20.2 million.
The EBITDA is a measure of a Thorne Healthtech's overall financial performance and is widely used to measure a its profitability.
To put Thorne Healthtech's EBITDA into context you can compare it against that of similar companies.
- Herbalife Nutrition (HLF.US): USD$524.9 million
- Cigna (CI.US): USD$9.4 billion
- CVS Health (CVS.US): USD$16.1 billion
Thorne Healthtech financials
| Revenue TTM | $258 million |
|---|---|
| Operating margin TTM | 5.42% |
| Gross profit TTM | $0 |
| Return on assets TTM | 3.7% |
| Return on equity TTM | 14.12% |
| Profit margin | 7.88% |
| Book value | $2.85 |
| Market Capitalization | $550.6 million |
TTM: trailing 12 months
Thorne Healthtech share dividends
We're not expecting Thorne Healthtech to pay a dividend over the next 12 months.
You may also wish to consider:
- Cigna (CI.US) (1.76% forward annual dividend yield)
- CVS Health (CVS.US) (4.68% forward annual dividend yield)
Thorne Healthtech share price volatility
Over the last 12 months, Thorne Healthtech's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Thorne Healthtech's is 0.8163. This would suggest that Thorne Healthtech's shares are less volatile than average (for this exchange).
To put Thorne Healthtech's beta into context you can compare it against those of similar companies.
- Herbalife Nutrition (HLF.US): 1.2
- Cigna (CI.US): 0.506
- CVS Health (CVS.US): 0.532
Thorne Healthtech overview
Thorne HealthTech, Inc. , a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to enhance and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.
Frequently asked questions
What percentage of Thorne Healthtech is owned by insiders or institutions?Currently 73.796% of Thorne Healthtech shares are held by insiders and 10.282% by institutions. How many people work for Thorne Healthtech?
Latest data suggests 544 work at Thorne Healthtech. When does the fiscal year end for Thorne Healthtech?
Thorne Healthtech's fiscal year ends in December. What is Thorne Healthtech's ISIN number?
Thorne Healthtech's international securities identification number is: US8852601090
More resources on Finder
More guides on Finder
-
How to buy Zentek stock (ZTEK)
Steps to owning and managing ZTEK, with 24-hour and historical pricing before you buy.
-
How to buy ATAI Life Sciences stock (Atai Life Sciences)
Steps to owning and managing ATAI, with 24-hour and historical pricing before you buy.
-
How to buy Seelos Therapeutics stock (SEEL)
Steps to owning and managing SEEL, with 24-hour and historical pricing before you buy.
-
How to buy Eli Lilly and Company stock (LLY)
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
-
How to buy Humana stock (HUM)
Steps to owning and managing HUM, with 24-hour and historical pricing before you buy.
-
How to buy Illumina stock (ILMN)
Steps to owning and managing ILMN, with 24-hour and historical pricing before you buy.
-
How to buy UnitedHealth Group Incorporated stock (UNH)
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
-
How to buy Pfizer stock (PFE)
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
-
How to buy Moderna stock (MRNA)
Steps to owning and managing MRNA, with 24-hour and historical pricing before you buy.
-
How to buy Johnson & Johnson stock (JNJ)
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Ask a question